Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemosensitization with Paclitaxel, Isotretinoin, and Interferon Alpha-2b in Cervical Cancer
NCT00138151Phase 2Terminated
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Mar 2001
- Primary completion
- Nov 2010
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel oral solution, isotretinoin, interferon alfa-2b in Cervical Cancer (CC), sponsored by University of Medicine and Dentistry of New Jersey. Started Mar 2001; status: terminated.
02
Drugs
paclitaxel oral solutionisotretinoininterferon alfa-2b
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00138151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138151.